- The Myeloma Beacon - https://myelomabeacon.org -
SNS01-T
By: Jessica Langholtz; Published: January 11, 2011 @ 4:38 pm | Comments Disabled
| Brand Name: | |
| Generic Name: | |
| Code Name: | SNS01-T |
| Company: | Senesco |
| FDA Clinical Phase: | 1/2 |
Description:
SNS01-T is a small inhibitory RNA molecule that blocks the expression of Factor 5A mRNA. The Factor 5A gene has been shown to regulate the expression of genes required for programmed cell death. SNS01-T is currently being developed for treatment of multiple myeloma for its potential to induce programmed cell death in cancerous cells.
Clinical Trials:
For a list of clinical trials studying SNS01-T for the treatment of multiple myeloma, see ClinicalTrials.gov [1].
Article printed from The Myeloma Beacon: https://myelomabeacon.org
URL to article: https://myelomabeacon.org/resources/2011/01/11/sns01-t/
URLs in this post:
[1] ClinicalTrials.gov: http://www.clinicaltrials.gov/ct2/results?term=sns01-t
Click here to print.
Copyright © The Beacon Foundation for Health. All rights reserved.